Mikami K - Search Results

1

Significance of serum tumor necrosis factor-related apoptosis-inducing ligand as a prognostic biomarker for renal cell carcinoma.

Toiyama D, Takaha N, Shinnoh M, Ueda T, Kimura Y, Nakamura T, Hongo F, Mikami K, Kamoi K, Kawauchi A, Miki T. Toiyama D, et al. Among authors: mikami k. Mol Clin Oncol. 2013 Jan;1(1):69-74. doi: 10.3892/mco.2012.35. Epub 2012 Oct 15. Mol Clin Oncol. 2013. PMID: 24649125 Free PMC article.

2

Prognostic significance of serum osteoprotegerin levels in patients with bladder carcinoma.

Mizutani Y, Matsubara H, Yamamoto K, Nan Li Y, Mikami K, Okihara K, Kawauchi A, Bonavida B, Miki T. Mizutani Y, et al. Among authors: mikami k. Cancer. 2004 Oct 15;101(8):1794-802. doi: 10.1002/cncr.20550. Cancer. 2004. PMID: 15386310 Free article.

3

Downregulation of Smac/DIABLO expression in renal cell carcinoma and its prognostic significance.

Mizutani Y, Nakanishi H, Yamamoto K, Li YN, Matsubara H, Mikami K, Okihara K, Kawauchi A, Bonavida B, Miki T. Mizutani Y, et al. Among authors: mikami k. J Clin Oncol. 2005 Jan 20;23(3):448-54. doi: 10.1200/JCO.2005.02.191. Epub 2004 Nov 30. J Clin Oncol. 2005. PMID: 15572731

4

Radio-frequency ablation of renal cell carcinoma in patients who were at significant risk.

Ukimura O, Kawauchi A, Fujito A, Mizutani Y, Okihara K, Mikami K, Soh J, Nakamura T, Nakanishi H, Ushijima S, Miki T. Ukimura O, et al. Among authors: mikami k. Int J Urol. 2004 Dec;11(12):1051-7. doi: 10.1111/j.1442-2042.2004.00966.x. Int J Urol. 2004. PMID: 15663674 Free article. Clinical Trial.

5

The significance of the expression of dihydropyrimidine dehydrogenase in prostate cancer.

Li Y, Mizutani Y, Shiraishi T, Nakamura T, Mikami K, Takaha N, Okihara K, Kawauchi A, Sakai T, Miki T. Li Y, et al. Among authors: mikami k. BJU Int. 2007 Mar;99(3):663-8. doi: 10.1111/j.1464-410X.2006.06606.x. Epub 2006 Nov 7. BJU Int. 2007. PMID: 17092280

6

Overexpression of XIAP expression in renal cell carcinoma predicts a worse prognosis.

Mizutani Y, Nakanishi H, Li YN, Matsubara H, Yamamoto K, Sato N, Shiraishi T, Nakamura T, Mikami K, Okihara K, Takaha N, Ukimura O, Kawauchi A, Nonomura N, Bonavida B, Miki T. Mizutani Y, et al. Among authors: mikami k. Int J Oncol. 2007 Apr;30(4):919-25. Int J Oncol. 2007. PMID: 17332931

7

[Squamous cell carcinoma of the renal pelvis with elevation of G-CSF in the serum: a case report].

Fujii H, Nakamura T, Mikami K, Okihara K, Mizutani Y, Kawauchi A, Miki T. Fujii H, et al. Among authors: mikami k. Hinyokika Kiyo. 2008 Nov;54(11):733-6. Hinyokika Kiyo. 2008. PMID: 19068728 Free article. Japanese.

8

Salvage chemotherapy with paclitaxel and gemcitabine plus nedaplatin (TGN) as part of multidisciplinary therapy in patients with heavily pretreated cisplatin-refractory germ cell tumors.

Shiraishi T, Nakamura T, Mikami K, Takaha N, Kawauchi A, Miki T. Shiraishi T, et al. Among authors: mikami k. Int J Clin Oncol. 2009 Oct;14(5):436-41. doi: 10.1007/s10147-009-0899-y. Epub 2009 Oct 25. Int J Clin Oncol. 2009. PMID: 19856053 Clinical Trial.

9

High mobility group protein AT-hook 1 (HMGA1) is associated with the development of androgen independence in prostate cancer cells.

Takeuchi I, Takaha N, Nakamura T, Hongo F, Mikami K, Kamoi K, Okihara K, Kawauchi A, Miki T. Takeuchi I, et al. Among authors: mikami k. Prostate. 2012 Jul 1;72(10):1124-32. doi: 10.1002/pros.22460. Epub 2011 Dec 27. Prostate. 2012. PMID: 22213442

10

[Management of side effects of everolimus treatment for metastatic renal cell carcinoma].

Mikami K, Hongo F, Miki T. Mikami K, et al. Hinyokika Kiyo. 2012 Nov;58(11):647-50. Hinyokika Kiyo. 2012. PMID: 23254794 Free article. Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

775 results

Search Page

Filters